News
The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...
21h
Stockhead on MSNBig pharma takes notice as Novo Nordisk puts Clever Culture’s APAS to the testClever Culture’s APAS is now on trial with Novo Nordisk, and if it delivers, this one machine could unlock a ... Read More ...
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...
The US Food and Drug Administration approved, the first rapid-acting interchangeable biosimilar product, Kirsty (insulin ...
On June 18, TD Cowen maintained its “Buy” rating on Novo Nordisk A/S (NYSE:NVO) with a price target of $105. This decision ...
DexCom has significant room to grow in its core market, despite disappointing results last year. One of Warren Buffett's ...
Novo Nordisk has submitted a new, higher dose of its obesity treatment, Wegovy, for approval to the European Medicines Agency ...
Terry Smith slammed two of Denmark’s largest life sciences companies — Novo Nordisk A/S and Coloplast A/S — after they ...
Novo Nordisk, a leading global healthcare company, is excited to announce a new Memorandum of Understanding with the Saudi ...
Clever Culture Systems Ltd (ASX: CC5), a leader in AI microbiology automation that provides intelligent automation solutions ...
Clever Culture Systems Ltd , a leader in AI microbiology automation, has announced the sale of an APASIndependence instrument to Novo Nordisk in Europe. Clever Culture Systems pro ...
Danish pharmaceutical giant Novo Nordisk has announced a new 800-million-yuan (approximately USD 111.9 million) investment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results